Rockwell Medical, Inc.RMTINASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-11.6%
5Y CAGR-23.5%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-11.6%/yr
vs -35.4%/yr prior
5Y CAGR
-23.5%/yr
Recent acceleration
Acceleration
+23.8pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.60 | +3.9% |
| 2023 | 0.58 | +160.5% |
| 2022 | 0.22 | -74.5% |
| 2021 | 0.87 | +5.2% |
| 2020 | 0.83 | -63.9% |
| 2019 | 2.30 | +50.7% |
| 2018 | 1.53 | -69.6% |
| 2017 | 5.02 | -15.1% |
| 2016 | 5.91 | -31.6% |
| 2015 | 8.64 | - |